ARANZ Medical an Innovators Award finalist

ARANZ Medical an Innovators Award finalist

CHRISTCHURCH, NZ., 10 September, 2015 – ARANZ Medical (www.aranzmedical.com) has been named a finalist in this year’s New Zealand Innovators Awards.

ARANZ Medical’s 3D scanning and information systems transform how skin is assessed to empower healthcare providers to address challenging medical problems in woundcare and orthotics/ prosthetics.

ARANZ Medical CEO Dr Bruce Davey says, “Innovation is at the heart of everything we do, so we’re very proud to have our work acknowledged in this way. We’re developing sophisticated yet easy-to-use medical technology to replace what were previously some of the most primitive processes in healthcare.”

ARANZ Medical's founders came up with an ingenious scanning device more than a decade ago – literally shedding light on changes in the skin.

Today, their state-of-the-art technology includes FastSCAN II, a second-generation 3D system supporting the custom-fitting of orthoses and prosthetics and other medical applications; and Silhouette, an FDA-approved advanced wound surveillance system which gathers accurate information to track wounds as they are healing.

Dr Davey says, “We’ve combined our skill in laser technology and IT to give researchers and clinicians alike important assessment information at a level of accuracy and ease that has not been possible before. Empowering better-informed decisions that could lead to better healing outcomes can help improve the lives of millions of people worldwide, including high risk groups such as diabetes sufferers and the elderly.”

ARANZ Medical are seeing a growing demand for their technology driven by increases in diseases like diabetes, an ageing population, more accountable healthcare and the emerging telehealth trend.

Over 40 million people around the world suffer from chronic wounds such as pressure ulcers, venous ulcers and diabetic ulcers, and wounds typically account for 2-4% of health expenditure and can lead to amputations, readmissions, social isolation, sepsis, significant pain, and death. Amputation rates are also increasing and every 30 seconds a lower limb is lost to diabetes somewhere in the world. Wounds and amputations are linked and it is believed that, with the right care, at least 50% of all diabetic leg amputations can be prevented.

The company’s technology is being used in over 30 countries in a range of settings, from clinical researchers in rural Africa studying the Buruli ulcer, one of the most neglected tropical diseases to the largest healthcare providers in the US.

ENDS

© Scoop Media